Intervention Protocol

Conventional interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy

  1. Martijn M Stuiver1,*,
  2. Marieke R ten Tusscher1,
  3. Carla S Agasi-Idenburg1,
  4. Cees Lucas2,
  5. Neil K Aaronson3,
  6. Patrick MM Bossuyt4

Editorial Group: Cochrane Breast Cancer Group

Published Online: 18 APR 2012

DOI: 10.1002/14651858.CD009765

How to Cite

Stuiver MM, ten Tusscher MR, Agasi-Idenburg CS, Lucas C, Aaronson NK, Bossuyt PMM. Conventional interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD009765. DOI: 10.1002/14651858.CD009765.

Author Information

  1. 1

    The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Department of Physiotherapy, Amsterdam, Netherlands

  2. 2

    Academic Medical Centre, University of Amsterdam, Department of Clinical Epidemiology, Biostatics and Bioinformatics, Amsterdam, Netherlands

  3. 3

    The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Department of Psychosocial Research, Division of Psychosocial Research & Epidemiology, Amsterdam, Netherlands

  4. 4

    Academic Medical Center, University of Amsterdam, Department of Clinical Epidemiology and Biostatistics, Amsterdam, Netherlands

*Martijn M Stuiver, Department of Physiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066CX, Netherlands. m.stuiver@nki.nl. m.m.stuiver@amc.uva.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 18 APR 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effectiveness of conventional therapies for prevention of lymphoedema in (specific subgroups of) patients who are at risk of developing lymphoedema after treatment for breast cancer.

To investigate the relative effectiveness of the different interventions.